" Creating a product that benefits others is the most rewarding work you can do"

Gloria Kolb’s journey from mechanical engineer to the CEO and co-founder of Elidah, Inc. is a remarkable testament to the power of innovation and perseverance in addressing long-overlooked issues in women’s health. As the visionary behind ELITONE®, a non-invasive treatment for urinary incontinence, Kolb has fundamentally changed the way millions of women approach this common yet often neglected condition. Her career has been defined by her commitment to solving real-world problems and creating meaningful solutions that improve lives—especially for women who often face unique healthcare challenges.

The seed for Kolb’s entrepreneurial journey was planted when she realized that women’s pelvic health, particularly incontinence, had been largely ignored by the medical innovation sector. Despite the fact that urinary incontinence affects millions of women worldwide, traditional treatments were either invasive or impractical for women leading busy lives. Kolb, a mother of three, was acutely aware of how challenging it was to balance personal health with the demands of everyday life. She understood that the available solutions, which often required extended periods of rest or invasive procedures, were not suited to the realities of modern life. This gap in the market led her to the creation of Elidah and its flagship product, ELITONE.

ELITONE is a groundbreaking wearable device that treats urinary incontinence using neuromuscular stimulation. Unlike conventional treatments, ELITONE is non-invasive, non-vaginal, and discreet, making it a practical option for women. Designed to be worn under clothing, the device allows women to continue with their daily activities while receiving treatment, providing a discreet solution that respects their busy lifestyles. By focusing on the real-life needs of women, Kolb and her team were able to create a product that not only addressed a prevalent health issue but also offered an elegant and effective solution that fit seamlessly into women’s daily routines.

While the innovation behind ELITONE was groundbreaking, the path to bringing it to market was filled with significant obstacles. Kolb and her husband, Eric, faced numerous challenges, particularly when it came to securing funding. The stigma surrounding incontinence led many investors to dismiss the product’s potential. Many potential backers, unfamiliar with the female health space, did not grasp the scale of the problem or the opportunity presented by such an innovative solution. Furthermore, Kolb and her team had to navigate a complex regulatory landscape to secure FDA approval for the device. Extensive clinical data and studies were required to demonstrate the safety and efficacy of the product, making the process lengthy and demanding. Yet, despite these obstacles, Kolb’s unwavering belief in the potential of ELITONE kept her and her team focused on their vision. Their persistence ultimately paid off when Elidah successfully secured the necessary funding and FDA clearance to bring ELITONE to market.